(Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces it has received lead clinical ... Our 2022 diabetes animal study DIAB-A22-1, utilizing ...
The Study, upon completion, is expected to be equally regarded as a Phase 1b registrational study by the U.S. Food and ... sugar control or weight loss? Does DehydraTECH processing enhance real world ...
Listen to Story If you're struggling with weight loss and ... and can be done best after finding out the root cause of inflammation. "These diets are also specialised for one's needs. For example, if ...